Application 209549
- Type
- ANDA
- Sponsor
- WATSON LABS TEVA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TERIFLUNOMIDE | TERIFLUNOMIDE | TABLET;ORAL | 7MG | No | No |
| 002 | TERIFLUNOMIDE | TERIFLUNOMIDE | TABLET;ORAL | 14MG | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A209549-001 | TERIFLUNOMIDE | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | ||
| A209549-002 | TERIFLUNOMIDE | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209549-001 | TERIFLUNOMIDE | 7MG | TABLET / ORAL | 2018-07-27 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A209549-002 | TERIFLUNOMIDE | 14MG | TABLET / ORAL | 2018-07-27 | 3a93d1ddd44b… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2023-12-20 04:57 UTC | 2023-12 | A209549-001 | PC | 2023-09-08 | ea1830bbd6c7… |
| 2023-12-20 04:57 UTC | 2023-12 | A209549-002 | PC | 2023-09-08 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209549-001 | PC | 2023-09-08 | a72a2bbeb626… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A209549-002 | PC | 2023-09-08 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209549-001 | PC | 2023-09-08 | 9b2671bbb829… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A209549-002 | PC | 2023-09-08 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209549-001 | PC | 2023-09-08 | a67488948f0b… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A209549-002 | PC | 2023-09-08 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209549-001 | PC | 2023-09-08 | 3f0d92c62455… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A209549-002 | PC | 2023-09-08 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A209549-001 | PC | 2023-09-08 | 053a50430f4f… |
| 2023-05-13 08:27 UTC | 2023-05 | A209549-002 | PC | 2023-09-08 | 053a50430f4f… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Teriflunomide | TERIFLUNOMIDE | Teva Pharmaceuticals, Inc. | c424959d-00c9-4e76-aba6-cc7464d8e903 | 2026-08-26 | Boxed warning, Warnings, Adverse reactions | Teriflunomide TERIFLUNOMIDE |
| TERIFLUNOMIDE | TERIFLUNOMIDE | CONCORD BIOTECH LIMITED | 2d2724f6-8812-4a26-b2ec-936b71f868e1 | 2026-05-06 | Boxed warning, Warnings, Adverse reactions | TERIFLUNOMIDE TERIFLUNOMIDE |
| Teriflunomide | TERIFLUNOMIDE | Zydus Pharmaceuticals USA Inc. | cbf32b27-e63a-4544-9c1f-6564e82200e5 | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | Teriflunomide TERIFLUNOMIDE |
| Teriflunomide | TERIFLUNOMIDE | Aurobindo Pharma Limited | 2fd80242-c607-4c50-b497-8259abb4a2f8 | 2026-04-01 | Boxed warning, Warnings, Adverse reactions | Teriflunomide TERIFLUNOMIDE |
| TERIFLUNOMIDE | TERIFLUNOMIDE | Alembic Pharmaceuticals Inc. | 8c1bc23b-a62b-4172-a603-8b97761514b4 | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | TERIFLUNOMIDE TERIFLUNOMIDE |
| teriflunomide | TERIFLUNOMIDE | Glenmark Pharmaceuticals Inc., USA | cb431ea0-ba0f-4b5d-a50d-f8c050762242 | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | teriflunomide TERIFLUNOMIDE |
| Aubagio | TERIFLUNOMIDE | Genzyme Corporation | 4650d12c-b9c8-4525-b07f-a2d773eca155 | 2026-02-20 | Boxed warning, Warnings, Adverse reactions | TERIFLUNOMIDE |
| Teriflunomide | TERIFLUNOMIDE | AvKARE | f9c95ed7-130f-9455-e053-6394a90a182f | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | Teriflunomide TERIFLUNOMIDE |
| Teriflunomide | TERIFLUNOMIDE | Accord Healthcare Inc. | 246d42e5-5418-42ba-aff9-ae399b166c69 | 2025-12-01 | Boxed warning, Warnings, Adverse reactions | Teriflunomide TERIFLUNOMIDE |
| Teriflunomide | TERIFLUNOMIDE | Biocon Pharma Inc. | 37f04f8b-001e-66ff-4574-cc34cebce61c | 2024-09-30 | Boxed warning, Warnings, Adverse reactions | Teriflunomide TERIFLUNOMIDE |
| Teriflunomide | TERIFLUNOMIDE | Zydus Lifesciences Limited | 58991a51-d40e-476f-8f5f-ac89e68e7107 | 2024-08-12 | Teriflunomide TERIFLUNOMIDE | |
| Teriflunomide | TERIFLUNOMIDE | Natco Pharma USA LLC | 8219b4a2-fb9d-4387-ba33-96d28aad71dd | 2024-01-02 | Boxed warning, Warnings, Adverse reactions | Teriflunomide TERIFLUNOMIDE |
| Teriflunomide | TERIFLUNOMIDE | Camber Pharmaceuticals, Inc. | 9b25c24e-a4a9-43b4-a33f-75bef3a96d5f | 2023-03-16 | Boxed warning, Warnings, Adverse reactions | Teriflunomide TERIFLUNOMIDE |
| TERIFLUNOMIDE | TERIFLUNOMIDE | Alembic Pharmaceuticals Limited | 2b084b44-f15b-4b16-b700-4382434f2136 | 2023-02-08 | Boxed warning, Warnings, Adverse reactions | TERIFLUNOMIDE TERIFLUNOMIDE |
| Teriflunomide | TERIFLUNOMIDE | MSN LABORATORIES PRIVATE LIMITED | 63ba28ef-5055-461a-99ef-c49e8ece4b54 | 2023-02-03 | Boxed warning, Warnings, Adverse reactions | Teriflunomide TERIFLUNOMIDE |
| Teriflunomide | TERIFLUNOMIDE | Mylan Pharmaceuticals Inc. | 1824aae5-58af-43da-8231-435c8f118bc0 | 2022-08-24 | Boxed warning, Warnings, Adverse reactions | Teriflunomide TERIFLUNOMIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 55198 | ORIG | 2018-08-17 |